Patents Assigned to Novagent Oy
  • Publication number: 20150182745
    Abstract: A device based on iontophoresis and intended for transdermal dosing of an active agent, said device comprising a pair of electrodes (11,12), which can be connected to a direct-current source, and two chambers (13, 14), separated from each other, the first chamber (13) containing the active agent, each chamber having a porous membrane (15, 16) on the side facing the individual's skin, and the first chamber (13) being divided in two sections (13a, 13b) in such a manner that the first chamber section (13a) is in contact with the electrode (11) and the second chamber section (13b) is in contact with the membrane (15) coming into contact with an individual's skin, wherein between the chamber sections (13a and 13b) is a membrane (18) selectively permeable either to cations or to anions, the first chamber section (13a) containing an electrolyte and the second chamber section (13b) containing the ionic active agent, bound to a ion exchanger therein, which in turn preferably comprises fibres and ion exchanging grou
    Type: Application
    Filed: July 31, 2013
    Publication date: July 2, 2015
    Applicant: NOVAGENT OY
    Inventors: Kyösti Kontturi, Jouni Hirvonen, Lauri Viitala, Maija Pohjakallio
  • Patent number: 6254883
    Abstract: A pharmaceutical composition for the controlled transdermal delivery of a drug containing a combination of a drug and an ion exchanger group to a carrier, and a pharmaceutically acceptable salt that is able to control the release of the drug from the ion exchanger, in which the carrier is a textile fiber. According to a preferred embodiment the drug is tacrine or its pharmaceutically acceptable salt.
    Type: Grant
    Filed: July 7, 1998
    Date of Patent: July 3, 2001
    Assignee: Novagent Oy
    Inventors: Risto Järnström, Jouni Hirvonen